Skip to main content
. 2022 Apr 4;7(6):1219–1228. doi: 10.1016/j.ekir.2022.03.028

Figure 4.

Figure 4

Serum levels of IgA1, Gd-IgA1, sC3, and C3a in patients with IgAN of 3 groups. a–d: IgA1, Gd-IgA1, sC3, and C3a levels, respectively. IgAN, IgA nephropathy; IgAN-MA, patients with IgAN with microangiopathic lesions; IgAN-AS, patients with IgAN with arteriosclerosis/arteriolosclerosis lesions; IgAN-NO, patients with IgAN without vascular lesions.